Total Payments
$5,173
2024 Payments
$310.32
Companies
44
Transactions
254
Medicare Patients
10,638
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$5,143 (99.4%)
Education$30.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,143 | 253 | 99.4% |
| Education | $30.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,207 | 55 | $0 (2024) |
| LEO Pharma Inc. | $499.81 | 29 | $0 (2021) |
| Amgen Inc. | $409.98 | 16 | $0 (2020) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $281.22 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $268.59 | 11 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $268.25 | 12 | $0 (2023) |
| Almirall LLC | $188.41 | 10 | $0 (2024) |
| Allergan, Inc. | $179.76 | 8 | $0 (2022) |
| GENZYME CORPORATION | $146.20 | 7 | $0 (2021) |
| Mayne Pharma Inc. | $135.09 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $310.32 | 13 | ABBVIE INC. ($105.41) |
| 2023 | $402.59 | 16 | ABBVIE INC. ($63.17) |
| 2022 | $571.89 | 25 | Regeneron Healthcare Solutions, Inc. ($111.22) |
| 2021 | $454.38 | 21 | ORGANOGENESIS INC. ($80.11) |
| 2020 | $205.51 | 10 | AbbVie Inc. ($67.55) |
| 2019 | $1,048 | 50 | AbbVie, Inc. ($418.74) |
| 2018 | $949.52 | 50 | AbbVie, Inc. ($259.55) |
| 2017 | $1,230 | 69 | LEO Pharma Inc. ($285.35) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Tempus AI, Inc | Merlin Test (Device) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: DERMATOLOGY | ||||||
| 08/22/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $23.81 | General |
| 08/12/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Dermatology | ||||||
| 07/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), ARAZLO | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Podiatry | ||||||
| 07/01/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $25.26 | General |
| 05/20/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), ARAZLO | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Podiatry | ||||||
| 05/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Podiatry | ||||||
| 03/05/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Dermatology | ||||||
| 01/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/21/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), ARAZLO | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Podiatry | ||||||
| 12/20/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: Dermatology | ||||||
| 10/31/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/11/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.36 | General |
| 09/20/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Dermatology | ||||||
| 08/31/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.21 | General |
| Category: Dermatology | ||||||
| 08/30/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.38 | General |
| 08/14/2023 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Dermatology | ||||||
| 06/06/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $22.45 | General |
| Category: DERMATOLOGY | ||||||
| 06/05/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,942 | 6,857 | $814,805 | $299,962 |
| 2022 | 23 | 2,648 | 6,314 | $767,520 | $287,472 |
| 2021 | 22 | 2,548 | 5,959 | $695,535 | $277,006 |
| 2020 | 24 | 2,500 | 5,943 | $673,030 | $243,660 |
Total Patients
10,638
Total Services
25,073
Medicare Billing
$1.1M
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 375 | 621 | $124,200 | $59,493 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 457 | 824 | $123,600 | $56,799 | 46.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 467 | 712 | $160,200 | $50,429 | 31.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 425 | 801 | $100,125 | $29,320 | 29.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 217 | 307 | $53,725 | $26,494 | 49.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 343 | 2,738 | $95,895 | $14,510 | 15.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 188 | 297 | $29,700 | $12,518 | 42.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 54 | 69 | $17,250 | $9,273 | 53.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 40 | 57 | $31,350 | $7,939 | 25.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 81 | 81 | $16,200 | $7,063 | 43.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $10,725 | $4,824 | 45.0% |
| 10040 | Acne surgery | Office | 2023 | 41 | 50 | $10,000 | $4,496 | 45.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 39 | 42 | $8,450 | $4,276 | 50.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 28 | 29 | $5,800 | $2,825 | 48.7% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $6,175 | $2,812 | 45.5% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 18 | 23 | $5,175 | $2,359 | 45.6% |
| 69100 | Biopsy of ear | Office | 2023 | 32 | 34 | $6,800 | $1,816 | 26.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $3,850 | $1,147 | 29.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 27 | 34 | $3,400 | $953.26 | 28.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 13 | $1,625 | $572.88 | 35.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 32 | 56 | $560.00 | $43.33 | 7.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 347 | 617 | $123,400 | $59,789 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 380 | 664 | $99,600 | $46,023 | 46.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 339 | 481 | $108,225 | $34,158 | 31.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 397 | 726 | $90,750 | $28,651 | 31.6% |
About Dr. Brian Katz, MD
Dr. Brian Katz, MD is a Dermatology healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013951755.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Katz, MD has received a total of $5,173 in payments from pharmaceutical and medical device companies, with $310.32 received in 2024. These payments were reported across 254 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($5,143).
As a Medicare-enrolled provider, Katz has provided services to 10,638 Medicare beneficiaries, totaling 25,073 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Miami Beach, FL
- Active Since 06/15/2006
- Last Updated 11/04/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1013951755
Products in Payments
- Humira (Biological) $836.10
- Enbrel (Biological) $379.42
- DUPIXENT (Biological) $258.13
- PICATO (Drug) $235.43
- ENSTILAR (Drug) $234.38
- COSENTYX (Biological) $209.61
- SKYRIZI (Biological) $187.91
- Klisyri (Drug) $177.56
- JUBLIA (Drug) $169.24
- BOTOX (Biological) $160.25
- DORYX (Drug) $135.09
- Otezla (Drug) $119.42
- TALTZ (Drug) $97.67
- RINVOQ (Biological) $79.21
- Yupelri (Drug) $74.56
- EUCRISA (Drug) $67.65
- Erivedge (Biological) $67.54
- NAFTIN (Drug) $65.60
- OPZELURA (Drug) $63.64
- DERMATITIS - DISEASE (Drug) $61.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Miami Beach
Roberta Del Campo, M.d, M.D
Dermatology — Payments: $141,536
Dermatology $141,536
Chere Lucas Anthony, M.d, M.D
Dermatology — Payments: $13,046
Dermatology $13,046
Benjamin Witkoff
Dermatology — Payments: $6,072
Dermatology $6,072
Maryann Mikhail, Md, MD
Dermatology — Payments: $4,611
Dermatology $4,611
Dr. Stephen Mandy, Md, MD
Dermatology — Payments: $4,080
Dermatology $4,080
Chloe Goldman
Dermatology — Payments: $3,107
Dermatology $3,107